Your browser doesn't support javascript.
loading
Multilayer omics analysis reveals a non-classical retinoic acid signaling axis that regulates hematopoietic stem cell identity.
Schönberger, Katharina; Obier, Nadine; Romero-Mulero, Mari Carmen; Cauchy, Pierre; Mess, Julian; Pavlovich, Polina V; Zhang, Yu Wei; Mitterer, Michael; Rettkowski, Jasmin; Lalioti, Maria-Eleni; Jäcklein, Karin; Curtis, Jonathan D; Féret, Betty; Sommerkamp, Pia; Morganti, Claudia; Ito, Keisuke; Ghyselinck, Norbert B; Trompouki, Eirini; Buescher, Joerg M; Pearce, Erika L; Cabezas-Wallscheid, Nina.
Afiliação
  • Schönberger K; Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany; Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany; International Max Planck Research School for Molecular and Cellular Biology (IMPRS-MCB), Freiburg, Germany.
  • Obier N; Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
  • Romero-Mulero MC; Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
  • Cauchy P; Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
  • Mess J; Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany; Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany; Spemann Graduate School of Biology and Medicine (SGBM), Freiburg, Germany; Centre for Integrative Biological Signalling Studies (CIBSS), Freiburg, Germ
  • Pavlovich PV; Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany; Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany; International Max Planck Research School for Molecular and Cellular Biology (IMPRS-MCB), Freiburg, Germany.
  • Zhang YW; Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany; Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany; International Max Planck Research School for Molecular and Cellular Biology (IMPRS-MCB), Freiburg, Germany.
  • Mitterer M; Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
  • Rettkowski J; Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany; Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany; Spemann Graduate School of Biology and Medicine (SGBM), Freiburg, Germany.
  • Lalioti ME; Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
  • Jäcklein K; Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
  • Curtis JD; Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
  • Féret B; Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), UMR 7104 Centre National de la Recherche Scientifique (CNRS) et Université de Strasbourg (UNISTRA), U1258 Institut National de la Santé et de la Recherche Médicale (INSERM), Illkirch, France.
  • Sommerkamp P; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Morganti C; Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Departments of Cell Biology and Medicine, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Ito K; Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Departments of Cell Biology and Medicine, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Ghyselinck NB; Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), UMR 7104 Centre National de la Recherche Scientifique (CNRS) et Université de Strasbourg (UNISTRA), U1258 Institut National de la Santé et de la Recherche Médicale (INSERM), Illkirch, France.
  • Trompouki E; Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
  • Buescher JM; Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
  • Pearce EL; Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany; The Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Johns Hopkins University, Baltimore, MD, USA.
  • Cabezas-Wallscheid N; Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany; Centre for Integrative Biological Signalling Studies (CIBSS), Freiburg, Germany. Electronic address: cabezas@ie-freiburg.mpg.de.
Cell Stem Cell ; 29(1): 131-148.e10, 2022 01 06.
Article em En | MEDLINE | ID: mdl-34706256
ABSTRACT
Hematopoietic stem cells (HSCs) rely on complex regulatory networks to preserve stemness. Due to the scarcity of HSCs, technical challenges have limited our insights into the interplay between metabolites, transcription, and the epigenome. In this study, we generated low-input metabolomics, transcriptomics, chromatin accessibility, and chromatin immunoprecipitation data, revealing distinct metabolic hubs that are enriched in HSCs and their downstream multipotent progenitors. Mechanistically, we uncover a non-classical retinoic acid (RA) signaling axis that regulates HSC function. We show that HSCs rely on Cyp26b1, an enzyme conventionally considered to limit RA effects in the cell. In contrast to the traditional view, we demonstrate that Cyp26b1 is indispensable for production of the active metabolite 4-oxo-RA. Further, RA receptor beta (Rarb) is required for complete transmission of 4-oxo-RA-mediated signaling to maintain stem cells. Our findings emphasize that a single metabolite controls stem cell fate by instructing epigenetic and transcriptional attributes.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tretinoína / Células-Tronco Hematopoéticas Idioma: En Revista: Cell Stem Cell Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tretinoína / Células-Tronco Hematopoéticas Idioma: En Revista: Cell Stem Cell Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha